London research firm expands, plans new family clinic
A London clinical research company is expanding its operations, including opening a new family health centre, after receiving…
20 years, 1,600 surgeries: London doctors’ mission restores mobility abroad
Operation Walk Canada made its first mission to Guatemala two decades ago, providing free hip and knee replacement…
Ontario offers medical-school funding for five-year family doctor commitment
More than 2,000 Ontario medical students will have their education costs covered by the province if they commit…
Ontario offers medical-school funding for five-year family doctor commitment
More than 2,000 Ontario medical students will have their education costs covered by the province if they commit…
20 years, 1,600 surgeries: London doctors’ mission restores mobility abroad
Operation Walk Canada made its first mission to Guatemala two decades ago, providing free hip and knee replacement…
Eli Lilly Could Become The World’s Top AI Firm? Jordi Visser Has Reasons To Believe Mounjaro Maker Could
Speaking on “The Pomp Podcast” with crypto investor and entrepreneur Anthony Pompliano Saturday, Visser said Eli Lilly’s more…
What’s Going On With Novo Nordisk Stock Thursday? – Novo Nordisk (NYSE:NVO)
Oral Semaglutide Shows Superior Glycaemic Control The phase 3a study evaluated oral semaglutide in patients aged 10–17 years…
Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake – Eli Lilly (NYSE:LLY)
Early Prescription Trends Show Slower Start For Lilly Reuters, citing IQVIA data, reported that Eli Lilly recorded 1,390…
Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic – Novo Nordisk (NYSE:NVO)
Novo Nordisk A/S (NYSE:NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a…
AI Bubble Fear? This Sector Is Quietly Surging While Tech Sinks – Amgen (NASDAQ:AMGN), Bristol-Myers Squibb (NYSE:BMY)
It hasn’t been an easy stretch for technology and AI stocks, with triple-digit year-to-date gainers like Palantir Technologies…
Novo Nordisk’s $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker – Novo Nordisk (NYSE:NVO)
In a presentation at the American Heart Association’s (AHA’s) 2025 Scientific Sessions, researchers on Tuesday shared data from…
Trump-Pfizer Deal Pushes Health Care To Best Rally In 5 Years – Agilent Technologies (NYSE:A), Biogen (NASDAQ:BIIB)
Investors cheered a breakthrough drug pricing agreement between President Donald Trump and Pfizer Inc. (NYSE:PFE), sparking a sector-wide…